share_log

EF Hutton Initiates Coverage On GT Biopharma With Hold Rating, Announces Price Target of $2

EF Hutton Initiates Coverage On GT Biopharma With Hold Rating, Announces Price Target of $2

EF Hutton以持有评级启动对GT Biophma的覆盖,宣布目标价为2美元
Benzinga Real-time News ·  2023/01/05 04:32

EF Hutton analyst Tony Butler initiates coverage on GT Biopharma (NASDAQ:GTBP) with a Hold rating and announces Price Target of $2.

EF Hutton分析师Tony·巴特勒对GT Biophma(纳斯达克:GTBP)发起持有评级,并宣布目标价为2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发